# Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)

> **NCT01388101** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DEVICE:** Electrosensing antibody probing system (e- Ab sensor)

## Key facts

- **NCT ID:** NCT01388101
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388101, "Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01388101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*